KalVista Presents Latest Sebetralstat Findings at AAAAI 2025 KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of new data on sebetralstat at the 2025 American Academy of Allergy, Asthma & Immunology (AAAAI) / World Allergy Organization (WAO) Joint Congress…
ATEC Announces Proposed Offering of Convertible Senior Notes Alphatec Holdings, Inc. (Nasdaq: ATEC), a company focused on revolutionizing spine surgery, has announced its intention to offer $300,000,000 in aggregate principal amount of convertible senior notes due 2030 (the “notes”) in…
Gensaic Partners with Novo Nordisk to Develop Next-Gen Precision Therapies Gensaic, Inc., a biotechnology firm specializing in AI-driven protein design and biological insights to discover ligands for tissue-selective intracellular delivery, has announced a new license and discovery collaboration with global…
Protagonist and Takeda Report Positive Phase 3 VERIFY Study Results of Rusfertide for Polycythemia Vera Protagonist Therapeutics, Inc. and Takeda have announced positive topline results from their Phase 3 VERIFY study of rusfertide, a first-in-class investigational hepcidin mimetic peptide therapeutic,…
Surgimate Partners with ImplantBase to Create Unified Surgical Management Platform Surgimate, a leading provider of surgical coordination software supported by Banneker Partners, has announced its strategic investment in ImplantBase, a top provider of inventory logistics and sales operations software for…
Employer Digital Heart Health Program Linked to Significant Cost Savings, Study Finds A recent study published in the esteemed health economics journal Value in Health reveals significant annual cost savings for employers offering the digital health program Hello Heart as…
Celltrion Receives EC Approval for Avtozma ®, Biosimilar of RoActemra ® Celltrion has announced that the European Commission (EC) has granted marketing authorization for Avtozma® (CT-P47), a biosimilar to RoActemra® (tocilizumab). This approval encompasses all the indications of its reference…
Tenovi and GenieMD Partner to Expand Remote Care and Boost Medication Adherence GenieMD and Tenovi have teamed up to enhance access to healthcare through innovative virtual care models, combining their strengths to offer a more seamless and connected healthcare experience.…
Flosonics Medical Secures $7.5M CAD Venture Debt to Scale Wearable Ultrasound Tech Flosonics Medical, a Canadian innovator in medical devices, has secured $7.5 million CAD in venture debt financing from RBCx. This funding, along with specialized support, will help accelerate…
QIAGEN Takes Legal Action to Protect IP in QuantiFERON and Latent TB Testing QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA) has filed a lawsuit against bioMérieux SA (EPA: BIM) for patent infringement, emphasizing its dedication to safeguarding the scientific…
BostonGene to Present AI-Powered Platform at 22nd Annual Japanese Society of Medical Oncology Meeting BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced its participation in the 22nd Annual Meeting of the Japanese Society of Medical Oncology…
Phase III Study: Xolair More Effective with Fewer Side Effects Than Oral Immunotherapy for Food Allergies Genentech, a member of the Roche Group, has announced new positive results from Stage 2 and Stage 3 of the NIH-sponsored Phase III OUtMATCH…